dihexa human trials status 2026 clinical trial Dihexa shows neurotrophic activity exceeding BDNF in preclinical studies DIHEXA dihexa clinical trials humans human

Updated 02/20/2020

Full refund if a licensed clinician determines this isn't right for you Clinician-prescribed Oversight Once a day, topical Frequency Medication, clinician, ongoing care Included What you can expect WEEK 1 3 You start applying once daily

RNA sequencing was performed to identify differentially expressed genes and enriched pathways

Better sleep drives higher nocturnal GH output, creating a positive feedback loop for tissue repair

We lack the specific enzyme required to synthesize it, which means we must obtain it every single day through our diet or supplementation

The injectable forms of GHK-Cu sold online are classified as unapproved drugs and "research chemicals." They have not been evaluated for safety or efficacy by the FDA, making it illegal for companies to market them for human consumption or medical treatment